LEF1 and neoplasm: However, the exact molecular players driving this axis have not yet been identified, with β-catenin/lymphoid enhancer-binding factor-1 or E-box-binding transcription factors (i.e., SNAIL or TWIST) being the first candidates due to structural promoter sequences and to data obtained in other tumor settings [14,20].